key: cord-0924005-ven705rr authors: Tirelli, Umberto; Chirumbolo, Salvatore title: COVID‐19 and cancer: A deadly pairing date: 2021-04-23 journal: Int J Cancer DOI: 10.1002/ijc.33600 sha: 169e074adbb53f06116ef142b0bde2aec0557094 doc_id: 924005 cord_uid: ven705rr nan 55 000 cases of breast cancer, 44 000 colon carcinoma, 44 000 lung carcinoma, 40 000 prostate cancer and 36 000 bladder tumors, confirming the big concern of cancer management in Italy during the COVID-19 pandemic. 4 As an exemplificative result, a recent study in the Maugeri's Foundation Hospital, Lombardy, reported that a reduction in cancer diagnosis and hospitalization of about 36% occurred in 2020. Only 469 patients accessed the healthcare units for cancer therapy respect to 632 patients in 2019, and only 72 patients were introduced in tumor treatment, respect to 90 patients in 2019. 5 to 2018, recommended to support and improve this positive trend. 6 The huge concern regarding how to address diagnosis of novel emerging cancers and to support patients' caregiving during the global crisis caused by SARS-CoV2 pandemic has expanded the scientific debate about cancer in the COVID era, as physicians are obviously aware of their duty in equally considering patients with cancer as well as patients with COVID-19. The COVID-19 impact is primarily on cancer diagnosis, but also to other pathologies, for example, cardiovascular and hematological diseases. Patients are less motivated to seek medical counseling, due to a widespread fear in attending healthcare units and hospitals, but also because physicians are quite absolutely captured in addressing pandemic and COVID-19 medical emergency. 7 A recent study reported that cancer caseload during the pandemic was reduced to 12%, (with prostate and central nervous system (CNS) tumors among the most pronounced) and at least 17% of physicians reported that patients deviated from their recommended therapy plans, because of pandemic and lockdown. 8 In particular, the most frequent deviations were associated with changes in department policies (77%) vs patient-specific deviations (20%) or modifications requested by patients themselves (3%). Rare deviations (less than 1%) were related to patients contracting COVID-19. 9 When examining waiting lists, they contained, at its worst, about 27% of patients who experienced a delay to radiotherapy of more than 28 days, despite the averaged wait time up-grew of a negligible extent (19.6 days vs 18.2 days). This occurred because more pressing cases were generally prioritized. 9 In addition, cancer patients may also represent a comorbidity of the utmost interest in COVID-19 pathogenesis and development. The general opinion is that having cancer would mean a higher risk to develop severity in COVID-19, so rapidly worsening also COVID-19 emergency, despite the existence of opposite opinions. Controversial data about whether cancer patients with COVID-19 have different ability to counteract the sickness makes this concern much more burdensome than before. The question if those patients must be introduced toward a preferential route in order to reduce the concerning impact of cancer on COVID-19 emergency is particularly crucial, particularly in the case of vaccination managing. Patients suffering from hematologic malignancies should be considered high priority for COVID-19 vaccination as high risk groups. No sound policy to address this big concern has been properly addressed so far. COVID-19 emergency should address the burdensome problem of patients with tumors, also in order to better manage SARS-CoV2 pandemic and COVID-19 pathology. In conclusion, politics should address this great concern by elaborating novel health strategies about COVID-19 emergency, in order to ensure the possibility to diagnose and treat cancer even in patients with COVID-19 and reduce pandemic exacerbation in the community. The impact of the COVID-19 pandemic on the short-term survival of patients with cancer in northern Portugal Cancer or COVID-19? A review of guidelines for safe cancer care in the wake of the pandemic Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal Impact of SARS-CoV-2 on provided healthcare. Evidence from the emergency phase in Italy. Front Public Health Impact of COVID-19 outbreak on cancer patient care and treatment: data from an outpatient oncology clinic in Lombardy (Italy). Cancers (Basel) Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care COVID-19 at the intersections of science, morality and practice -reflections of the physician's soul a systematic analysis for the global burden of disease study 2017 Catching the wave: quantifying the impact of COVID on radiotherapy delivery Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study. Lancet Child Adolesc Health